Product Description
Methylergometrine Maleate Tablets IP, strength 0.125 mg per tablet, are a praiseworthy solution for the prevention and control of postpartum hemorrhage. Marketed and manufactured in adherence to Indian Pharmacopoeia (IP) standards, these first-rate allopathic tablets are famed for swift oral access, excellent efficacy, and cost-effective benefits. The round, white tablets are prescription-only and carefully packaged in blister strips to maintain quality. Acknowledged for their trusted uterotonic/hemostatic action, these tablets are indispensable for adult women post-delivery. Please refer to product packaging for specific manufacturer details.
Versatile Application Across Healthcare Settings
Methylergometrine Maleate Tablets IP are suitable for use in a range of clinical and maternity care applications. Their reliable uterotonic properties make them ideal for managing postpartum hemorrhage and uterine atony in hospitals, clinics, and healthcare facilities. Owing to their user-friendly oral administration and precise dosage form, these tablets are accessible for adult women under physician supervision. Always use as directed to ensure optimal therapeutic outcomes and patient safety.
Sample Policy and Seamless Domestic Supply
Methylergometrine Maleate Tablets IP are available for sampling, with purchase orders ensuring prompt dispatch. Our sample policy is designed to accommodate first-time buyers and healthcare providers, offering samples on request. Shipped from reputed FOB ports within India, our cost-effective distribution focuses on delivering the lowest prices without compromising quality. We cater extensively across the main domestic market, assuring reliable access for hospitals, clinics, and resellers nationwide.
FAQ's of Methylergometrine Maleate Tablets IP:
Q: How should Methylergometrine Maleate Tablets IP be administered?
A: The tablets are for oral use only and should be taken as directed by a physician, specifically following prescribed dosage and guidance for adult women.
Q: What is the main benefit of Methylergometrine Maleate Tablets IP?
A: These tablets are acclaimed for their efficacy in preventing and controlling postpartum hemorrhage and uterine atony, ensuring maternal safety after childbirth.
Q: When is the ideal time to use Methylergometrine Maleate Tablets IP?
A: They are administered after childbirth when there is a risk or occurrence of postpartum hemorrhage, under the supervision and instruction of a healthcare provider.
Q: Where are these tablets manufactured and what standards do they comply with?
A: These tablets are manufactured in India, complying with the Indian Pharmacopoeia (IP) for quality and safety as indicated on the product packaging.
Q: What is the process for ordering and receiving samples?
A: Interested parties can place a purchase order to request samples. Once processed, samples are shipped promptly from the designated FOB port, ensuring timely supply to the main domestic market.